Oral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shifts

Findings indicate oral vancomycin induces remission in PSC-IBD, with notable microbiota changes and inflammation reduction, reversing after treatment ends.

How did hospitalizations for mental health conditions in children change following the COVID-19 pandemic?

The incidence of mental health conditions in young people before and during Canada’s coronavirus disease 2019 (COVID-19) pandemic.

July 11, 2024

New communication tool reduces sick leave in patients with Medically Unexplained Physical Symptoms

Medically Unexplained Physical Symptoms (MUPS) are characterized by persistent bodily symptoms and functional impairment that lack an explanation through known medical condition or pathology.

October 17, 2023

Philips Receives FDA 510(k) Clearance on Image-Guided Surgical Therapy

What You Should Know: – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its Philips Zenition 30 mobile C-arm has

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.